These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15778736)

  • 1. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.
    Wallace JL; Devchand PR
    Br J Pharmacol; 2005 Jun; 145(3):275-82. PubMed ID: 15778736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modeling damage of the mucous membrane of the gastrointestinal tract in rats].
    Trubitsyna IE; Drozdov VN; Tkachenko EV; Varvanina GG
    Eksp Klin Gastroenterol; 2011; (2):117-20. PubMed ID: 21560651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric mucosal defense and cytoprotection.
    Tulassay Z; Herszényi L
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):99-108. PubMed ID: 20227024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of cyclooxygenase inhibition in animal models.
    Radi ZA
    Toxicol Pathol; 2009 Jan; 37(1):34-46. PubMed ID: 19234234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors and gastrointestinal mucosal injury: pharmacological and therapeutic considerations.
    Dajani EZ; Agrawal NM
    J Assoc Acad Minor Phys; 2000; 11(2-3):28-31. PubMed ID: 10953541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Confocal endomicroscopy: should we change our approach to the endoscopic diagnosis of the mucosal lesions of the gastrointestinal tract?].
    Pellisé Urquiza M
    Gastroenterol Hepatol; 2010 Apr; 33(4):267-70. PubMed ID: 20356652
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosal biopsy of the gastrointestinal tract.
    Whitehead R
    Major Probl Pathol; 1979; 3():1-241. PubMed ID: 762991
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathology of graft-versus-host disease in the gastrointestinal tract.
    Washington K; Jagasia M
    Hum Pathol; 2009 Jul; 40(7):909-17. PubMed ID: 19524102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal biopsy of the gastrointestinal tract.
    Whitehead R
    Major Probl Pathol; 1973; 3():1-202. PubMed ID: 4588357
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
    Lanas A; Sopeña F
    Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Era of the mucosal biopsy.
    Goldman H
    Monogr Pathol; 1990; (31):1-10. PubMed ID: 2406571
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
    Brzozowski T
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-culture methods in the study of gastrointestinal-mucosal function and development.
    Trier JS
    N Engl J Med; 1976 Jul; 295(3):150-5. PubMed ID: 775333
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of metaplastic and heterotopic epithelia in the human gastrointestinal tract by the expression pattern of acyl-CoA synthetase 5.
    Gassler N; Obermüller N; Keith M; Schirmacher P; Autschbach F
    Histol Histopathol; 2005 Apr; 20(2):409-14. PubMed ID: 15736044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.